Search Results - "Zambrana Tébar, Francisco"

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy by Sereno, María, Gutiérrez-Gutiérrez, Gerardo, Rubio, Juan Moreno, Apellániz-Ruiz, María, Sánchez-Barroso, Lara, Casado, Enrique, Falagan, Sandra, López-Gómez, Miriam, Merino, María, Gómez-Raposo, César, Rodriguez-Salas, Nuria, Tébar, Francisco Zambrana, Rodríguez-Antona, Cristina

“…Oxaliplatin is a chemotherapy agent active against digestive tumors. Peripheral neuropathy is one of the most important dose-limiting toxicity of this drug. It…”
Get full text

A significant response to sorafenib in a woman with advanced lung adenocarcinoma and a BRAF non-V600 mutation by Sereno, María, Moreno, Victor, Moreno Rubio, Juan, Gómez-Raposo, César, García Sánchez, Sagrario, Hernández Jusdado, Rebeca, Falagan, Sandra, Zambrana Tébar, Francisco, Casado Sáenz, Enrique

“…Lung adenocarcinoma includes recurrent activating oncogenic mutations (EGFR, EML4-ALK, ROS1) that have been associated with response to EGFR and ALK…”
Get full text

Oxaliplatin induced-neuropathy in digestive tumors by Sereno, María, Gutiérrez-Gutiérrez, Gerardo, Gómez-Raposo, César, López-Gómez, Miriam, Merino-Salvador, Maria, Tébar, Francisco Zambrana, Rodriguez-Antona, Cristina, Casado, Enrique

“…Abstract Oxaliplatin is one of the main drugs used in digestive tumors treatment. Peripheral neuropathy is a well-recognized dose-limiting toxicity of OXL. Two…”
Get full text